9 Ways Menopause Affects Your Lungs and Breathing Capacity
When breathlessness started showing up on walks that used to feel easy, the last thing on the radar was menopause. It felt like aging, or fitness slipping — not hormones. Finding out that estrogen has a direct hand in airway inflammation genuinely changed how this symptom was understood and managed, and it deserved to be on the list long before it was.
Learn more about Rose →Estrogen Loss Increases Airway Inflammation
Estrogen has well-documented anti-inflammatory effects on the bronchial epithelium — the tissue lining the airways. When estrogen levels fall during perimenopause and menopause, inflammatory mediators like mast cells and eosinophils become less suppressed, making the airways more reactive and prone to swelling. This is one of the core physiological reasons why new-onset asthma is significantly more common in women after menopause than before it.
New-Onset Asthma Peaks After Menopause
Before puberty, boys develop asthma more than girls — but after puberty and especially after menopause, the pattern reverses sharply in women's disfavor. Large epidemiological studies, including data from the European Community Respiratory Health Survey, have found that postmenopausal women have a measurably higher incidence of new asthma diagnoses than premenopausal women of similar age. This is not a coincidence; it tracks directly with the estrogen withdrawal timeline.
Lung Function Measurements Decline Faster After Menopause
FEV1 (forced expiratory volume in one second) and FVC (forced vital capacity) — the two key metrics of lung function — naturally decline with age in everyone, but research shows the rate of decline accelerates in women after menopause compared to men of the same age. Studies suggest this accelerated decline is at least partially attributable to the loss of estrogen's protective effects on respiratory muscle strength and airway patency. The practical result is reduced breathing reserve, particularly noticeable during exercise or illness.
Progesterone Loss Reduces the Drive to Breathe
Progesterone is a known respiratory stimulant — it acts on the brainstem's respiratory control centers to increase the drive and depth of breathing. During the reproductive years, progesterone levels rise each luteal phase and during pregnancy, which is why breathing actually improves for some women with asthma during pregnancy. As both progesterone and estrogen drop in menopause, this stimulant effect disappears, potentially contributing to blunted breathing depth and a reduced ventilatory response to low oxygen levels during sleep.
Sleep-Disordered Breathing Becomes More Common
Obstructive sleep apnea is far more prevalent in postmenopausal women than in premenopausal women of comparable weight and age, with some studies estimating the risk doubles or triples after menopause. The loss of progesterone's upper-airway muscle-toning effect, combined with changes in fat distribution toward the neck and trunk, both contribute to airway collapse during sleep. Many women attribute their poor sleep quality entirely to hot flashes without realizing that interrupted breathing may also be playing a significant role.
Increased Susceptibility to Respiratory Infections
Estrogen supports mucosal immunity in the respiratory tract, influencing the production of secretory IgA and the behavior of immune cells in the airway lining. With declining estrogen, the mucosal defense layer becomes less robust, which may explain why postmenopausal women tend to experience more frequent and more prolonged respiratory infections than their premenopausal counterparts. This isn't about immune system failure broadly — it's a specific vulnerability in the airway tissue itself.
Vasomotor Symptoms Can Mimic Breathing Problems
Hot flashes involve sudden, intense shifts in skin blood flow and core temperature, and they frequently produce a sensation of breathlessness or chest tightness that has nothing to do with the lungs structurally. This overlap can make it genuinely difficult — even for clinicians — to distinguish true respiratory symptoms from vasomotor events without careful history-taking. Women who notice breathlessness arriving in waves, accompanied by heat or flushing, may be experiencing vasomotor-driven breathing sensations rather than a primary lung condition.
Exercise-Induced Breathlessness Increases Even Without Fitness Loss
Some women in perimenopause notice they become breathless at exercise intensities that previously felt comfortable, even when their cardiovascular fitness has not objectively declined. Reduced airway diameter from inflammation, lower respiratory muscle endurance, and blunted ventilatory responses all contribute to a higher perceived breathing effort during exertion. This can become a discouraging cycle — breathlessness reduces activity, which then genuinely declines fitness, compounding the problem.
Hormone Therapy Has a Measurable — but Complex — Effect on Airways
The relationship between menopausal hormone therapy (MHT) and respiratory health is not entirely straightforward. Some studies, including data from the Women's Health Initiative, found that combined estrogen-progestogen therapy was associated with a slightly increased risk of asthma or asthma-like symptoms, possibly because synthetic progestogens behave differently from natural progesterone. Other research shows estrogen-only therapy may be more protective for lung function, and emerging evidence on body-identical progesterone suggests a different risk profile — but this area is still being studied, and decisions about MHT should always be made with an informed clinician.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.